[{"Assets_0_Q3_USD":1072329000.0,"CommonStockSharesOutstanding_0_Q3_shares":36011725.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":144927000.0,"NetIncomeLoss_1_Q3_USD":23977000.0,"NetIncomeLoss_3_Q3_USD":70630000.0,"StockholdersEquity_0_Q3_USD":692007000.0,"EarningsPerShareBasic_1_Q3_USD":0.67,"EarningsPerShareBasic_3_Q3_USD":1.97,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":35939000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":35829000.0,"Ticker":"MEDP","CIK":"1668397","name":"MEDPACE HOLDINGS, INC.","OfficialName":"Medpace Holdings Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5256127036.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191029"}]